Hospital closure leads to layoffs in Indiana | Inside Indiana Business
Pennsylvania-based Select Medical Holdings Corp. has announced plans to lay off 103 employees in Fort Wayne, Ind. In a notice to the state of Indiana, the company says the layoffs are the result of the closure of its Select Specialty Hospital in the city.
Supporters Of Boston Children's Garden Ask State To Reconsider Approval Of Hospital Expansion | Public Radio WBUR.com
Supporters of Prouty Garden — a historic healing garden for patients at Boston Children's Hospital — are asking state officials to re-consider their approval of a planned hospital expansion that would see the garden demolished.
As scare over rare prion disease eases, Maine Medical Center resumes surgeries | Portland (Maine) Press Herald
The Portland hospital completes a precautionary sterilization of equipment while awaiting test results on a patient who showed signs of the fatal brain condition.
Hospitals at home launch in Boston | Boston Globe
As insurers and consumers struggle with ever-climbing hospital bills, the Brigham and Massachusetts General Hospital have launched programs that could seem counterintuitive: sending attending physicians, nurses and equipment into patients' homes as a way to reduce healthcare costs while still providing safe and reliable care.
Registered nurses at St. Catherine of Siena Medical Center in Smithtown and St. Charles in Port Jefferson- two hospitals in the Catholic Health System on Long Island-announced today that they have overwhelmingly approved new contracts.
HHS watchdog office steps up focus on drug pricing | Statnews.com
Seeking to address rising concerns about prescription medicines, HHS' watchdog arm is adding to its list of pharmaceutical issues to be examined. The HHS Office of Inspector General regularly compiles reports on such matters, whether in response to requests from Congress or to follow up issues, but is trying to widen its focus as questions accelerate about drug costs and the sources for some medicines, according to a new work plan released today.
Valeant Pharmaceuticals International, the drugmaker that became a poster child for high drug prices during the U.S. election season, may change its name to help boost its reputation, board member and top investor William Ackman told CNBC on Wednesday.